Searched by
Category - cancer
| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TS-TCR01-1 |
Human TCR Tetramer-PE (HLA-A*24:02 survivin-2B80-88-AYACNTSTL) |
|||||
|
cancer | PE | 50 tests | ¥275,000 |
0 (Contact us) |
||
| 4°C | |||||||
|
TS-M546-2 |
H-2Db gp100 Tetramer-EGSRNQDWL-APC |
|
||||
|
cancer | APC | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EGSRNQDWL | 25-33 | 4°C | |||||
|
TS-M081-1 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| LLGRNSFEV | 264-272 | 4°C | |||||
|
TC-5116-1 |
H-2Kb RPL18 Neoepitope Tetramer-KILTFDRL-PE |
|
||||
|
cancer | PE | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KILTFDRL | 4°C | ||||||
|
TS-M091-2 |
HLA-A*24:02 MCPyV large T Ag Tetramer-EWWRSGGFSF-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EWWRSGGFSF | 92-101 | 4°C | |||||
|
TS-M519-1 |
T-Select H-2Ld P815 Tetramer-LPYLGWLVF-PE |
|
||||
|
cancer | PE | H-2Ld | 50 tests | ¥209,000 | 1-9 | |
| LPYLGWLVF | 35-43 | 4°C | |||||
|
TS-M518-1 |
T-Select H-2Db CEA Tetramer-EAQNTTYL-PE |
|
||||
|
cancer | PE | H-2Db | 50 tests | ¥209,000 | 1-9 | |
| EAQNTTYL | 526-533 | 4°C | |||||
|
TS-M073-2 |
HLA-A*24:02 MAGE-A2 Tetramer-EYLQLVFGI-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 | 1-9 | |
| EYLQLVFGI | 156-164 | 4°C | |||||
|
TS-M089-2 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VYFFLPDHL | 170-178 | 4°C | |||||
|
TS-M081-2 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| LLGRNSFEV | 264-272 | 4°C | |||||
|
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| RMFPNAPYL | 126-134 | 4°C | |||||
|
TS-M078-2 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLYDGMEHL | 254-262 | 4°C | |||||
|
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KASEKIFYV | 41-49 | 4°C | |||||
|
TS-M077-2 |
HLA-A*24:02 MAGE-A3 Tetramer-IMPKAGLLI-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| IMPKAGLLI | 195-203 | 4°C | |||||
|
TS-M084-2 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TLADFDPRV | 883-891 | 4°C | |||||
|
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KASEKIFYV | 41-49 | 4°C | |||||
|
TS-M112-1 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 | 1-9 | |
| EYRALQLHL | 219-227 | 4°C | |||||
|
TS-M083-2 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLQDASAEV | 126-134 | 4°C | |||||
|
TS-M091-1 |
HLA-A*24:02 MCPyV large T Ag Tetramer-EWWRSGGFSF-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EWWRSGGFSF | 92-101 | 4°C | |||||
|
TS-M544-1 |
H-2Kd JAK1 Tetramer-SYFPEITHI-PE |
|
||||
|
cancer | PE | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYFPEITHI | 367-375 | 4°C | |||||
|
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| TLADFDPRV | 883-891 | 4°C | |||||
|
TS-M071-2 |
HLA-B*07:02 MAGE-A1 Tetramer-RVRFFFPSL-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RVRFFFPSL | 289-297 | 4°C | |||||
|
TS-M083-1 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLQDASAEV | 126-134 | 4°C | |||||
|
TS-M112-2 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EYRALQLHL | 219-227 | 4°C | |||||
|
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLLPAIVEL | 402-410 | 4°C | |||||
|
TS-M544-2 |
H-2Kd JAK1 Tetramer-SYFPEITHI-APC |
|
||||
|
cancer | APC | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYFPEITHI | 367-375 | 4°C | |||||
|
TS-M545-2 |
H-2Kd Erk2 K136Q Tetramer-QYIHSANVL-APC |
|
||||
|
cancer | APC | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QYIHSANVL | 136-144 | 4°C | |||||
|
TC-5116-2 |
H-2Kb RPL18 Neoepitope Tetramer-KILTFDRL-APC |
|
||||
|
cancer | APC | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KILTFDRL | 4°C | ||||||
|
TS-M545-1 |
H-2Kd Erk2 K136Q Tetramer-QYIHSANVL-PE |
|
||||
|
cancer | PE | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QYIHSANVL | 136-144 | 4°C | |||||
|
TS-5004-4C |
H-2Kb TRP-2 Tetramer-SVYDFFVWL-BV421 |
|
||||
|
cancer | BV421 | H-2Kb | 50 tests | ¥209,000 | 1-9 | |
| SVYDFFVWL | 180-188 | 4°C | |||||
|
TC-5113-4 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-BV421 |
|
||||
|
cancer | BV421 | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ASMTNMELM | 4°C | ||||||
|
TS-M075-4 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVAELVHFL | 112-120 | 4°C | |||||
|
TC-5115-1 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-PE |
|
||||
|
cancer | PE | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SSPYSLHYL | 4°C | ||||||
|
TC-5113-2 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-APC |
|
||||
|
cancer | APC | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ASMTNMELM | 4°C | ||||||
|
TC-5114-1 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-PE |
|
||||
|
cancer | PE | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AQLANDVVL | 4°C | ||||||
|
TC-0129-1 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-PE |
|
||||
|
cancer | PE | B*35:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MPFATPMEA | 94-102 | 4°C | |||||
|
TC-5116-4 |
H-2Kb RPL18 Neoepitope Tetramer-KILTFDRL-BV421 |
|
||||
|
cancer | BV421 | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KILTFDRL | 4°C | ||||||
|
TC-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EYILSLEEL | 298-306 | 4°C | |||||
|
TS-M075-2 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVAELVHFL | 112-120 | 4°C | |||||
|
TC-0108-1 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RISTFKNWPK | 4°C | ||||||
|
TS-M011-4 |
HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| SLLMWITQC | 157-165 | 4°C | |||||
|
TC-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
TC-5102-1 |
H-2Kb Survivin Tetramer-MFFCFKEL-PE |
|
||||
|
cancer | PE | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MFFCFKEL | 4°C | ||||||
|
TC-5105-2 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-APC |
|
||||
|
cancer | APC | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYVKVLHHM | 4°C | ||||||
|
TC-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | 4°C | |||||
|
TS-M562-4 |
H-2Kb mTERT Tetramer-VGRNFTNL-BV421 |
|
||||
|
cancer | BV421 | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VGRNFTNL | 4°C | ||||||
|
TC-0167-4 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421 |
|
||||
|
cancer | BV421 | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
TC-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | 4°C | |||||
|
TC-5108-4 |
H-2Db Survivin Tetramer-ATFKNWPFL-BV421 |
|
||||
|
cancer | BV421 | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ATFKNWPFL | 20-28 | 4°C | |||||
|
TS-0019-4C |
HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YMDGTMSQV | 4°C | ||||||
|
TS-M561-4 |
H-2Db hPSA Tetramer-HCIRNKSVIL-BV421 |
|
||||
|
cancer | BV421 | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HCIRNKSVIL | 4°C | ||||||
|
TC-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | 4°C | |||||
|
TC-5115-4 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-BV421 |
|
||||
|
cancer | BV421 | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SSPYSLHYL | 4°C | ||||||
|
TC-0119-1 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | 4°C | |||||
|
TC-5104-1 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-PE |
|
||||
|
cancer | PE | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYMLQALCI | 4°C | ||||||
|
TC-0169-2 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | ||||||
|
TS-M014-4 |
HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-BV421 |
|
||||
|
cancer | BV421 | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CYTWNQMNL | 235-243 | 4°C | |||||
|
TS-M505-4 |
H-2Db human gp 100 Tetramer-KVPRNQDWL-BV421 |
|
||||
|
cancer | BV421 | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVPRNQDWL | 25-33 | 4°C | |||||
|
TS-0009-4C |
HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| ELAGIGILTV | 26-35 | 4°C | |||||
|
TC-0140-2 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EYILSLEEL | 298-306 | 4°C | |||||
|
TC-5114-4 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-BV421 |
|
||||
|
cancer | BV421 | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AQLANDVVL | 4°C | ||||||
|
TS-0013-4C |
HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| IMDQVPFSV | 209-217 | 4°C | |||||
|
TC-5102-4 |
H-2Kb Survivin Tetramer-MFFCFKEL-BV421 |
|
||||
|
cancer | BV421 | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MFFCFKEL | 4°C | ||||||
|
TC-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
|
||||
|
cancer | BV421 | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EYILSLEEL | 298-306 | 4°C | |||||
|
TC-5102-2 |
H-2Kb Survivin Tetramer-MFFCFKEL-APC |
|
||||
|
cancer | APC | H-2Kb | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MFFCFKEL | 4°C | ||||||
|
TC-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | |||||
|
TC-5108-2 |
H-2Db Survivin Tetramer-ATFKNWPFL-APC |
|
||||
|
cancer | APC | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ATFKNWPFL | 20-28 | 4°C | |||||
|
TC-5115-2 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-APC |
|
||||
|
cancer | APC | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SSPYSLHYL | 4°C | ||||||
|
TC-0108-4 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-BV421 |
|
||||
|
cancer | BV421 | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RISTFKNWPK | 4°C | ||||||
|
TC-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | |||||
|
TC-5104-2 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-APC |
|
||||
|
cancer | APC | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYMLQALCI | 4°C | ||||||
|
TS-0015-4C |
HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KIFGSLAFL | 369-377 | 4°C | |||||
|
TC-0129-2 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-APC |
|
||||
|
cancer | APC | B*35:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MPFATPMEA | 94-102 | 4°C | |||||
|
TC-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | |||||
|
TS-0035-4C |
HLA-A*02:01 gp100 154-162 Tetramer-KTWGQYWQV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KTWGQYWQV | 154-162 | 4°C | |||||
|
TS-M074-4 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-BV421 |
|
||||
|
cancer | BV421 | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| EVDPIGHLY | 168-176 | 4°C | |||||
|
TC-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | 4°C | |||||
|
TC-0139-1 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CYASGWGSI | 153-161 | 4°C | |||||
|
TC-0139-2 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CYASGWGSI | 153-161 | 4°C | |||||
|
TC-5105-1 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-PE |
|
||||
|
cancer | PE | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYVKVLHHM | 4°C | ||||||
|
TS-0014-4C |
HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ITDQVPFSV | 209-217 | 4°C | |||||
|
TC-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | 4°C | |||||
|
TC-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | |||||
|
TC-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | |||||
|
TS-0017-4 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | 4°C | |||||
|
TC-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | |||||
|
TC-5108-1 |
H-2Db Survivin Tetramer-ATFKNWPFL-PE |
|
||||
|
cancer | PE | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ATFKNWPFL | 20-28 | 4°C | |||||
|
TC-5114-2 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-APC |
|
||||
|
cancer | APC | H-2Db | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AQLANDVVL | 4°C | ||||||
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | 4°C | |||||
|
TS-M074-2 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-APC |
|
||||
|
cancer | APC | A*01:01 | 50 tests | ¥209,000 | 1-9 | |
| EVDPIGHLY | 168-176 | 4°C | |||||
|
TC-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
|
||||
|
cancer | BV421 | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | 4°C | ||||||
|
TC-0129-4 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-BV421 |
|
||||
|
cancer | BV421 | B*35:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MPFATPMEA | 94-102 | 4°C | |||||
|
TC-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | |||||
|
TC-0166-1 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLAVGATK | 4°C | ||||||
|
TC-5104-4 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-BV421 |
|
||||
|
cancer | BV421 | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYMLQALCI | 4°C | ||||||
|
TC-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | |||||
|
TC-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
|
||||
|
cancer | BV421 | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | |||||
|
TC-0139-4 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-BV421 |
|
||||
|
cancer | BV421 | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CYASGWGSI | 153-161 | 4°C | |||||
|
TC-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | |||||
|
TS-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| SLLMWITQV | 157-165 | 4°C | |||||